Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study

Abstract

Methadone maintenance treatment is proven to be effective treatment for opioid dependence. Of the many adverse events reported, sexual dysfunction is one of the most common side effects. However, there may be other clinical factors that are associated with sexual dysfunction among methadone users. We conducted a meta-analysis to examine the clinical factors associated with sexual dysfunction among male patients on methadone and buprenorphine treatments, of which eligible studies were selected using prior defined criteria. A total of 2619 participants from 16 eligible studies, published from inception till December 2012, were identified from the PubMed, OVID and EMBASE databases. The included studies provided prevalence estimates for sexual dysfunction among methadone users with a meta-analytical pooled prevalence of 52% (95% confidence interval (CI), 0.39–0.65). Only four studies compared sexual dysfunction between the two groups, with a significantly higher combined odds ratio in the methadone group (odds ratio=4.01, 95% CI, 1.52–10.55, P=0.0049). Our study shows that eight clinical factors are associated with sexual dysfunction among men receiving opioid substitution treatment, namely age, hormone assays, duration of treatment, methadone dose, medical status, psychiatric illness, other current substance use and familial status, and methadone versus buprenorphine treatment. Despite the methodological limitations, the findings of this meta-analysis study may offer better insights to clinicians in dealing with both sexual dysfunction and its related problems.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Laumann EO, Paik A, Rosen RC . Sexual dysfunction in the United States. JAMA 1999; 281: 537–544.

    Article  CAS  Google Scholar 

  2. Macdonald S, Halliday J, MacEwan T, Sharkey V, Farrington S, Wall S et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction case–control study. Br J Psychiatry 2003; 182: 50–56.

    Article  CAS  Google Scholar 

  3. Rosen RC . Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000; 2: 189–195.

    Article  CAS  Google Scholar 

  4. Grube M, Weigand-Tomiuk H . Sexual dysfunctions in a group of psychiatric in-patients]. Psychiatrische Praxis 2002; 29: 194.

    Article  Google Scholar 

  5. Oksuz E, Malhan S . The prevalence of male sexual dysfunction and potential risk factors in Turkish men: a Web-based survey. Int J Impot Res 2005; 17: 539–545.

    Article  CAS  Google Scholar 

  6. Mattick RP, Breen C, Kimber J, Davoli M . Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; CD002209.

  7. Teusch L, Scherbaum N, Böhme H, Bender S . Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment: results of an investigation by semi-structured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry 1995; 28: 84–92.

    Article  CAS  Google Scholar 

  8. Cicero TJ, Bell RD, Wiest WG, Allison JH, Polakoski K, Robins E . Function of the male sex organs in heroin and methadone users. N Engl J Med 1975; 292: 882–887.

    Article  CAS  Google Scholar 

  9. Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J . Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sexual Med 2008; 5: 684–692.

    Article  CAS  Google Scholar 

  10. Patricia A, Cioe R, Peter D, Friedmann M, Stein MD . Erectile dysfunction in opioid users: lack of association with serum testosterone. J Addict Dis 2010; 29: 455–460.

    Article  Google Scholar 

  11. Brown R, Balousek S, Mundt M, Michael Fleming MDM . Methadone maintenance and male sexual dysfunction. J Addict Dis 2005; 24: 91–106.

    Article  Google Scholar 

  12. Chen W, Li X, Li X, Ling L, Xia Y, Chen J et al. Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China. J Addict Med 2012; 6: 212–218.

    Article  CAS  Google Scholar 

  13. Zhang Y, Wang P, Ma Z, Xu Z, Li Y . Sexual function of 612 male addicts treated by methadone. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011; 36: 739.

    PubMed  Google Scholar 

  14. Nik Jaafar NR, Mislan N, Abdul Aziz S, Baharudin A, Ibrahim N, Midin M et al. Risk factors of erectile dysfunction in patients receiving methadone maintenance therapy. J Sexual Med 2013; 10: 2069–2076.

    Article  Google Scholar 

  15. Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmüller D . Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 2005; 90: 203–206.

    Article  CAS  Google Scholar 

  16. Giacomuzzi S, Khreis A, Riemer Y, Garber K, Ertl M . Buprenorphine and methadone maintenance treatment-sexual behaviour and dysfunction prevalence. Lett Drug Design Discov 2009; 6: 13-.

    Article  CAS  Google Scholar 

  17. Tatari F, Farnia V, Najafi F . Trazodone in methandone induced erectile dysfunction. Iran J Psychiatry 2010; 5: 164–166.

    PubMed  PubMed Central  Google Scholar 

  18. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160–174.

    Article  Google Scholar 

  19. Chekuri V, Gerber D, Brodie A, Krishnadas R . Premature ejaculation and other sexual dysfunctions in opiate dependent men receiving methadone substitution treatment. Addict Behav 2012; 37: 124–126.

    Article  Google Scholar 

  20. Hanbury R, Cohen M, Stimmel B . Adequacy of sexual performance in men maintained on methadone. Am J Drug Alcohol Abuse 1977; 4: 13–20.

    Article  CAS  Google Scholar 

  21. Quaglio G, Lugoboni F, Pattaro C, Melara B, Mezzelani P, Des Jarlais DC . Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug and Alcohol Depen 2008; 94: 12–18.

    Article  CAS  Google Scholar 

  22. Baharudin A, Mislan N, Ibrahim N, Sidi H, Nik Jaafar NR . Depression in male patients on methadone maintenance therapy. Asia-Pacific Psychiatry 2013; 5: 67–73.

    Article  Google Scholar 

  23. Spring WD, Willenbring ML, Maddux TL . Sexual dysfunction and psychological distress in methadone maintenance. Subst Use Misuse 1992; 27: 1325–1334.

    Google Scholar 

  24. Peugh J, Belenko S . Alcohol, drugs and sexual function: a review. J Psychoactive Drugs 2001; 33: 223–232.

    Article  CAS  Google Scholar 

  25. Emanuele MA, Emanuele NV . Alcohol’s effects on male reproduction. Alcohol Health Res World 1998; 22: 195–201.

    CAS  PubMed  Google Scholar 

  26. Colameco S, Coren JS . Opioid-induced endocrinopathy. J Am Osteopath Assoc 2009; 109: 20–25.

    PubMed  Google Scholar 

  27. Peate I . The effects of smoking on the reproductive health of men. Br J Nurs 2005; 14: 362–367.

    Article  Google Scholar 

  28. Fronczak CM, Kim ED, Barqawi AB . The insults of illicit drug use on male fertility. J Androl 2012; 33: 515–528.

    Article  CAS  Google Scholar 

  29. Moher D, Liberati A, Tetzlaff J, Altman DG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.

    Article  Google Scholar 

  30. McAnulty RD, Burnette MM . Sex and sexuality. Greenwood Publishing Group, 2006.

    Google Scholar 

  31. Lofwall MR, Stitzer ML, Bigelow GE, Strain EC . Comparative safety and side effect profiles of buprenorphine and methadone in the outpatient treatment of opioid dependence. Addict Disord Treat 2005; 4: 49–64.

    Article  Google Scholar 

  32. Yule M, Davison J, Brotto L . The international index of erectile function: a methodological critique and suggestions for improvement. J Sex Marital Ther 2011; 37: 255–269.

    Article  Google Scholar 

  33. Rosen D, Smith ML, Reynolds CF III . The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatric Psych 2008; 16: 488–497.

    Article  Google Scholar 

  34. Mendelson JH, Mendelson JE, Patch VD . Plasma testosterone levels in heroin addiction and during methadone maintenance. J Pharmacol Exp Ther 1975; 192: 211–217.

    CAS  PubMed  Google Scholar 

  35. Mendelson J, Meyer R, Ellingboe J, Mirin S, McDougle M . Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther 1975; 195: 296–302.

    CAS  PubMed  Google Scholar 

  36. Woody G, McLellan A, O’Brien C, Persky H, Stevens G, Arndt I et al. Hormone secretion in methadone-dependent and abstinent patients. NIDA Res Monogr 1988; 81: 216–223.

    CAS  PubMed  Google Scholar 

  37. Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J . Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 2009; 32: 131–139.

    Article  CAS  Google Scholar 

  38. Xia Y, Zhang D, Li X, Chen W, He Q, Jahn HJ et al. Sexual dysfunction during methadone maintenance treatment and its influence on patient's life and treatment: a qualitative study in South China. Psychol Health Med 2013; 18: 321–329.

    Article  Google Scholar 

  39. Daniell HW . Narcotic-induced hypogonadism during therapy for heroin addiction. J Addict dis 2002; 21: 47–53.

    Article  Google Scholar 

  40. Colameco S, Coren JS, Zimmerman DJ . Buprenorphine-induced symptomatic hypogonadism in men: case reports and discussion. J Addict Med 2008; 2: 147–150.

    Article  CAS  Google Scholar 

  41. Dürsteler-MacFarland KM, Fischer DA, Mueller S, Schmid O, Moldovanyi A, Wiesbeck GA . Symptom complaints of patients prescribed either oral methadone or injectable heroin. J Subs Abuse Treat 2010; 38: 328–337.

    Article  Google Scholar 

  42. Grönbladh L, Öhlund LS . Self-reported differences in side-effects for 110 heroin addicts during opioid addiction and during methadone treatment. Heroin Addict Relat Clin Probl 2011; 13: 5–12.

    Google Scholar 

  43. Novick DM, Richman BL, Friedman JM, Friedman JE, Fried C, Wilson JP et al. The medical status of methadone maintenance patients in treatment for 11–18 years. Drug Alcohol Depend 1993; 33: 235–245.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Yee.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yee, A., Loh, H., Hisham Hashim, H. et al. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study. Int J Impot Res 26, 161–166 (2014). https://doi.org/10.1038/ijir.2014.18

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2014.18

This article is cited by

Search

Quick links